AzTrials
AzTrials

Patient SatisfactionNCT05607238

Patient Perspective Midline Catheter in the Emergency Department

A study testing Ultrasound Guided Vascular Access - Midline catheter and Ultrasound Guided Vascular Access - peripheral IV in people with Patient Satisfaction and Patient Preference, run by Wake Forest University Health Sciences.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study examines the patient satisfaction and perspective on the use of ultrasound guided midline intravenous catheters compared to standard ultrasound guided peripheral catheters. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Patient Satisfaction, Patient Preference
What is being tested?
Ultrasound Guided Vascular Access - Midline catheter and Ultrasound Guided Vascular Access - peripheral IV
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
May 2023to Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient in the emergency department
  • Failed 2 or more conventional attempts at vascular access *or*
  • history of requiring US guided vascular access
  • US Fellowship trained physician available

Who cannot join

  • basilic vein access is contraindicated
  • patient undergoing advanced resuscitation

About this study

Official title: Patient Perspective of Midline Catheters Versus Ultrasound Guided Peripheral IVs for Difficult IV Access in the ED

This study examines the patient satisfaction and perspective on the use of ultrasound guided midline intravenous catheters compared to standard ultrasound guided peripheral catheters.

Being tested
Ultrasound Guided Vascular Access - Midline catheter, Ultrasound Guided Vascular Access - peripheral IV
Keywords
IV access, ultrasound guided IV, emergency care
Medical subject headings
Patient Satisfaction, Patient Preference

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound Guided Vascular Access - Midline catheterProcedure or surgery

    Ultrasound guided vascular access with a midline IV catheter

  • Ultrasound Guided Vascular Access - peripheral IVProcedure or surgery

    Ultrasound guided vascular access with a peripheral IV catheter

Study groups in NCT05607238
Study groupRoleWhat they receive
Ultrasound Guided Peripheral IVActive comparatorPlacement of 4-5cm angiocath under ultrasound guidance
Receives: Procedure: Ultrasound Guided Vascular Access - peripheral IV
Ultrasound Guided Midline CatheterExperimentalPlacement of 10-15cm midline catheter under ultrasound guidance
Receives: Procedure: Ultrasound Guided Vascular Access - Midline catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Satisfaction with Procedure

    Score describes a patient's satisfaction with a healthcare decision. It measures satisfaction across 6 domains via 6 questions scored on a 5 point scale. Score ranges from 6 to 30. A low score signifies dissatisfaction, a high score signifies high satisfaction.

    Measured: Immediately after procedure/Baseline

  2. Patient Satisfaction with Procedure

    Score describes a patient's satisfaction with a healthcare decision. It measures satisfaction across 6 domains via 6 questions scored on a 5 point scale. Score ranges from 6 to 30. A low score signifies dissatisfaction, a high score signifies high satisfaction.

    Measured: At 48 Hours Post Baseline

Secondary outcomes (10)
  1. Number of needle punctures in a 24 hour period (patient reported)

    Measured: up to 48 hours

  2. Duration of Successful Access

    IV/Cath dwell time in hours

    Measured: up to 48 hours

  3. Number of Needle Sticks

    Prior to gaining successful access

    Measured: up to 48 hours

  4. Number of Insertion Attempts

    For ultrasound guided access

    Measured: up to 48 hours

  5. Emergency Department (ED) Length of Stay

    in hours

    Measured: up to 48 hours

  6. Hospital Length of Stay

    in hours

    Measured: up to 48 hours

  7. Patient Satisfaction

    this is a single question measuring satisfaction with the intervention overall on a Likert Scale 1-10,

    Measured: immediately post intervention/baseline and at 48 hours past baseline

  8. Number of Insertion Related Complications

    Includes failed attempts, arterial punctures, infiltrations, hematoma formations

    Measured: up to 48 hours

  9. Number of Dwell Related Complications

    Includes inability to flush, catheter dislodgement, leakage around the catheter site, insertion site erythema, insertion site pain, drainage from catheter, edema, ecchymosis, superficial thrombosis, Deep vein thrombosis (DVT), line associated infection, vesicant extravasation, skin necrosis, neurovascular injury, arterial injury

    Measured: up to 48 hours

  10. Time to Access

    minutes from procedure start to procedure completion

    Measured: up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2022
  2. Study startMay 2023 (estimated)
  3. Primary completionSep 2023 (estimated)
  4. Study completionSep 2023 (estimated)

Why it stopped: One of the key physicians is leaving the institution and other delays have put us behind our timeline. We do not intend to proceed with the trial at this time.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05607238
Sponsor's protocol ID
IRB00089914
Status last verified
Oct 2022
First submitted
13 Oct 2022
Last updated
2 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound Guided Vascular Access - Midline catheter and Ultrasound Guided Vascular Access - peripheral IV in people with Patient Satisfaction and Patient Preference, run by Wake Forest University Health Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 2 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Satisfaction with Procedure (time frame: Immediately after procedure/Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in